COVID-19: tobacco smoking and other risk factors in the elderly

[1]  F. Lu,et al.  Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study , 2020, BMC Infectious Diseases.

[2]  Dave Singh,et al.  COVID-19 and COPD: a narrative review of the basic science and clinical outcomes , 2020, European Respiratory Review.

[3]  J. Mehta,et al.  Smoking Doubles the Mortality Risk in COVID-19: A Meta-Analysis of Recent Reports and Potential Mechanisms , 2020, Cureus.

[4]  J. Greenbaum,et al.  Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity , 2020, Cell.

[5]  F. Reis,et al.  ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis , 2020, Ageing Research Reviews.

[6]  D. Sin,et al.  Smoking, ACE-2 and COVID-19: ongoing controversies , 2020, European Respiratory Journal.

[7]  T. Galbadage,et al.  Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes , 2020, Frontiers in Medicine.

[8]  L. C. Pinto,et al.  Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis , 2020, Archives of endocrinology and metabolism.

[9]  V. Ranieri,et al.  Predictors of Severe Respiratory Failure in Hospitalized Patients with SARS-CoV-2 Infection: Development and Validation of a Prediction Model (PREDI-CO Study) , 2020, SSRN Electronic Journal.

[10]  D. Farina,et al.  Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients , 2020, La radiologia medica.

[11]  E. Holmes,et al.  The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.

[12]  M. Parascandola,et al.  Tobacco and the lung cancer epidemic in China. , 2019, Translational lung cancer research.

[13]  Cheng Hu,et al.  Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication , 2017, Diabetes.

[14]  Mohammad A. Almazroa,et al.  Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014 , 2016, Emerging infectious diseases.

[15]  P. Mccombe,et al.  Gender differences in autoimmune disease , 2014, Frontiers in Neuroendocrinology.

[16]  E. Fish,et al.  SeXX matters in immunity. , 2014, Trends in immunology.

[17]  Tao Chen,et al.  Prevalence of Hypertension in China: A Cross-Sectional Study , 2013, PloS one.

[18]  V. Taneja,et al.  HLA Class II Molecules Influence Susceptibility versus Protection in Inflammatory Diseases by Determining the Cytokine Profile , 2013, The Journal of Immunology.

[19]  O. Tsang,et al.  Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong Kong , 2003, Annals of Internal Medicine.

[20]  Truls Østbye,et al.  A longitudinal study of the effects of tobacco smoking and other modifiable risk factors on ill health in middle-aged and old Americans: results from the Health and Retirement Study and Asset and Health Dynamics among the Oldest Old survey. , 2002, Preventive medicine.

[21]  F. Khuri,et al.  Long-term impact of smoking on lung epithelial proliferation in current and former smokers. , 2001, Journal of the National Cancer Institute.

[22]  A. W. Rogers,et al.  Recovery of bronchial epithelium on stopping smoking. , 1981, British medical journal.